pteridines has been researched along with HIV in 2 studies
HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Ram, RR | 1 |
Duatschek, P | 1 |
Margot, N | 1 |
Abram, M | 1 |
Geleziunas, R | 1 |
Hesselgesser, J | 1 |
Callebaut, C | 1 |
Tsai, A | 1 |
Irrinki, A | 1 |
Kaur, J | 1 |
Cihlar, T | 1 |
Kukolj, G | 1 |
Sloan, DD | 1 |
Murry, JP | 1 |
2 other studies available for pteridines and HIV
Article | Year |
---|---|
Activation of HIV-specific CD8
Topics: Anti-HIV Agents; CD8-Positive T-Lymphocytes; Dose-Response Relationship, Drug; Flow Cytometry; HIV; | 2020 |
Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
Topics: Anti-Retroviral Agents; Antibody-Dependent Cell Cytotoxicity; CD8-Positive T-Lymphocytes; Cell Diffe | 2017 |